Page 1701 - Clinical Small Animal Internal Medicine
P. 1701
Index 1639
TPE see therapeutic plasma exchange trauma, triage, and tracking TSH see thyroid‐stimulating
VetBooks.ir tracheobronchomalacia 290–291 treatment trials 1394 TSHR see thyrotropin receptor
3
hormone; transsphenoidal
Tpit see T‐box transcription factor
(tFAST ) 291–293, 293
hypophysectomy
Treg see regulatory T cells
traction injury 819
transesophageal echocardiography 152 tremor syndromes 769–770 TTW see transtracheal wash
transient myocardial thickening Treppe effect 177 tube agglutination test (TAT) 964
(TMT) 273 triage tuberculosis (TB) 980–984
transmissible venereal tumor Animal Trauma Triage tularemia 955–957
(TVT) 1314–1315 Score 455, 456 diagnosis 956–957
transsphenoidal hypophysectomy behavioral problems 1572–1574, epidemiology 955–956, 956
(TSH) 62–63 1573 etiology/pathophysiology 955
transtentorial herniation 750, 750 critical care setting 347 history and clinical signs 956
transtracheal wash (TTW) 307, 309 trauma, triage, and tracking public health implications 957
transudative effusions 334, 337–338 291–293, 293 signalment 956
trauma and burns 445–457 triceps reflex 735 treatment and prognosis 957
acute phase response 446 trichoblastoma 1354 tumor‐induced osteomalacia
alopecia 1433 trichoepithelioma 1355 (TIO) 1527
burns 446–447, 449, 455–457, trichography 1392, 1438 tumor‐node‐metastasis (TNM)
544, 545 trichomoniasis 1019–1020, 1019 staging 1200
central nervous system Trichophyton mentagrophytes hemangiosarcoma 1341–1342,
trauma 741–758 1428, 1430 1342
coagulation and inflammation 445 trichoscopy 1451, 1457–1458, 1458 mammary cancer 1322, 1322, 1324,
developmental orthopedic tricuspid regurgitation 227, 228 1324
diseases 1541 tricuspid valve dysplasia (TVD) 231, mast cell tumors 1361
diagnosis 448–449 234, 237 melanoma 1352, 1352
epidemiology 447 trigeminal nerve 738–739, TVD see tricuspid valve dysplasia
etiology/pathophysiology 445–447 825–826, 826 TVT see transmissible venereal tumor
history and clinical signs 447–448 triglycerides type 1 errors see false positives
intraocular tumors 1266 liver disease 650–651 type 2 errors see false negatives
ischemia and reperfusion 446 metabolic diseases 678–679 typhlitis 500, 501
myelopathy 821 pleural effusion 342 typhus group Rickettsia see
oral cavity and salivary urolithiasis 1127 spotted fever and typhus group
glands 544, 545 triiodothyronine see thyroid Rickettsia
primary phase 449–450 hormones tyrosine kinase inhibitors (TKI)
prognosis 455–457, 456 trombiculosis 1459–1460 atopic dermatitis 1411
rectoanal diseases 618 diagnosis 1460 biology of cancer and cancer
respiratory pattern‐based approach history and clinical signs genetics 1209
to dyspnea 294 1459–1460, 1460 cardiac neoplasia 1274
secondary phase 450–455 treatment and prognosis 1460 hemangiosarcoma 1344
septic shock 424 troponin 239–240 mast cell tumors 1364, 1366
signalment 447 trypanosomiasis 1006–1009
skeletal development and African trypanosomiasis and u
homeostasis 1516–1519 T. evansi 1008–1009 UACR see urine aldosterone to
surgical, traumatic, and bite wound American trypanosomiasis creatinine ratio
infections 1029–1034 1007–1008 UAP see ununited anconeal process
systemic inflammatory diagnosis 1008–1009, 1009 UCCR see urine cortisol to creatinine
response 445 epidemiology 1007–1008 ratio
traumatic brain injury/spinal cord etiology/pathophysiology 1007 UCM see unclassified cardiomyopathy
injury 446, 455 history and clinical signs UES see upper esophageal sphincter
treatment 449–455 1007–1008 UFH see unfractionated heparin
vestibular disease 792 signalment 1007–1008 ulceration
see also wound care treatment and prognosis allergic skin diseases 1416
traumatic brain injury 446, 455 1008–1009 approach to the dermatologic
traumatic diaphragmatic herniation/ trypsin‐like immunoreactivity patient 1385
avulsion 382 (TLI) 585–586, 603, 608 atopic dermatitis 1406